Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Plasma (Octaplas LG) - Octapharma

Next Previous
Search
Drug Profile

Plasma (Octaplas LG) - Octapharma

Alternative Names: Octaplas (US) - Octapharma; Octaplas LG; OctaplasLG; Plasma (OctaplasLG) - Octapharma

Latest Information Update: 22 Aug 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Octapharma
  • Class Anti-infectives; Anti-inflammatories; Antihaemorrhagics; Blood products and substitutes
  • Mechanism of Action Blood coagulation factor stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Blood coagulation disorders; Haemorrhage; Thrombotic thrombocytopenic purpura
  • Phase II Septic shock

Most Recent Events

  • 20 Aug 2024 Octapharma establishes Cooperative Research and Development Agreement (CRADA) with U.S. Army Medical Research and Development Command for the freeze-dried plasma product (octaplasLG Powder)
  • 08 Aug 2024 US FDA approves emergency use authorization of OctaplasLG® for treatment of Haemorrhage in USA
  • 30 Mar 2021 Launched for Blood coagulation disorders (In children, In adolescents) in USA (IV)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top